ArticleAnnals of medicine and surgery (2012)2025
The mortality rate and years of life lost due to cancer in a City of North of Islamic Republic of Iran during the years 2013-2021: joinpoint regression analysis.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Endocrine and neurological complications in total versus completion thyroidectomy: a systematic review and meta-analysis.BMC endocrine disorders · 2026Pooled it
- Global burden of thyroid cancer attributable to metabolic risk factors in women of reproductive age (20-49 years): a GBD 2021 cross-national analysis with projections to 2050.BMC women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: By providing a comprehensive analysis of incidence, mortality, and disability, cancer burden studies are tools for cancer control planning. The present study investigates the mortality rate and the years of life lost (YLL) due to cancers in a 9-year period. Methods: All registered cancer deaths in a city of north of Iran during 2013-2021 were considered. Crude, standardized mortality, and YLL of cancers were calculated for different age and sex groups. Also, to check the trend of the YLL, the joinpoint regression has been utilized. Results: During the study years (2013-2021), 3294 cancer deaths occurred. The total YLL because of cancer in the 9 years of the study were 22 228 (9 per 1000 people) in males, 20 824 (8.6 per 1000 people) in females, and 43 052 (8.8 per 1000 people) in both sexes. The average YLL due to malignancy was 11.7 years in males and 15.0 years in females. The highest percentage of YLL in men was caused by cancers of digestive organs and respiratory organs, and in women, cancers of digestive organs and breast. Conclusion: The YLL because of cancer were increasing in both men and women. Addressing the prevention of the underlying causes of YLL - especially gastrointestinal and breast cancers - may significantly affect overall life expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.